Sangoma Technologies Corporation (SANG) Misses Q1 EPS by 5c, provides guidance

Sangoma Technologies Corporation (NASDAQ: SANG) reported Q1 EPS of $(0.04), $0.05 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $58.1 million versus the consensus estimate of $64.08 million.

GUIDANCE:

Sangoma Technologies Corporation sees FY2025 revenue of $235-240 million, versus the consensus of $236.9 million. And reaffirming its Adjusted EBITDA2 guidance of $40 - $42 million, at approximately 17% of revenue given the results for the first three quarters of Fiscal 2025.

For earnings history and earnings-related data on Sangoma Technologies Corporation (SANG) click here.

You May Also Be Interested In

• Wolfe Research Downgrades T-Mobile (TMUS) to Peerperform
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c